Back to search results

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Abroad (travel likely)Recruiting

Conditions

Inflammatory Bowel Disease (IBD) · Crohn's Disease · Ulcerative Colitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Tulane University, New Orleans, Louisiana, United States

    Contact: Study coordinator (Lauren Griffin-Scudari) · lgriffinscudari@tulane.edu
    Contact: Principal Investigator (Sarah Glover, DO)

  • Capital Digestive Care, Chevy Chase, Maryland, United States

    Contact: Study coordinator (Gilbert Horst) · Ghorst@jointopo.com · 301-654-2521
    Contact: Principal Investigator (Erica Cohen, MD)

  • New York University, New York, New York, United States

    Contact: Study coordinator (Nathasha Melukkaran) · Nathasha.Melukkaran@nyulangone.org · 646-754-3417
    Contact: Principal Investigator (Jordan Axelrad)

  • University of North Carolina, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Emily English) · emily_english@med.unc.edu · 919-843-8105
    Contact: Principal Investigator (Millie Long, MD)

  • University of Cincinnati, Cincinnati, Ohio, United States

    Contact: Study coordinator (Renee Henry) · henryr4@ucmail.uc.edu · 513-558-5504
    Contact: Study coordinator (Loretta Randolph) · randollj@ucmail.uc.edu · 513-558-5529
    Contact: Principal Investigator (Kara De Felice, MD)

  • Vanderbilt University, Nashville, Tennessee, United States

    Contact: Study coordinator (Michael McGill) · michael.g.mcgill@vumc.org
    Contact: Principal Investigator (Sara Horst, MD)
Study leads

  • Raymond K Cross, MD, MS

    Principal Investigator

    Mercy Medical Center

View source on ClinicalTrials.gov(opens in a new tab)